Get access

Recurrence of Cutaneous Necrosis in an Infant with Probable Catastrophic Antiphospholipid Syndrome

Authors


Address correspondence to Soledad Camacho-Lovillo, M.D., Department of Pediatric Infectious Diseases and Immunology, Hospital Infantil Virgen del Rocío, Seville, Spain, or e-mail: marisolcl@ono.com.

Abstract

Abstract:  We present the case of a 3-month-old child with probable catastrophic antiphospholipid syndrome who, after initial successful management with immunomodulary therapies including rituximab, experienced a cutaneous relapse. This rare event was successfully re-treated with repeated administration of rituximab, supporting its role in the control of this disorder. Dermatologic manifestations may be the main clinical presentation of antiphospholipid syndrome, a possible underdiagnosed but potentially fatal pathology.

Get access to the full text of this article

Ancillary